LOINC Code 94588-1: Myeloid neoplasm chromosome analysis Mate pair sequencing Doc (Bld/BM)

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Myeloid neoplasm chromosome analysis. It is commonly used with the system or sample type Bld/Bone mar.

When is it used?

• Used in lab systems, EHRs, and clinical data exchange.
• May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
• Status: ACTIVE
• Order vs observation: Both
• Method: Mate pair sequencing

What it does not mean

• The code identifies the observation or test, not the actual result.

Key facts

• Myeloid neoplasm chromosome analysis in Blood or Marrow by Mate pair sequencing
• Myeloid neoplasm chromosome analysis
• This term is used for the order & overall chromosome analysis report for identification of neoplastic clones in blood or bone marrow specimens by mate pair sequencing in patient's with myeloid malignancies, such as acute myeloid leukemia (AML). Results may include the overall findings, the result in ISCN format, testing methods, interpretation, recommendations, and references. Testing is performed when previous cytogenetic studies are unsuccessful or detect a chromosome abnormality of unknown significance.
• Bld/Mar; Blood; BM; BON; Bone marrow; Chrom analy; Chromosom; Chromosomes; Cytogenetics; Document; Finding; Findings; Genetics; Hematology; Heme; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Karyotype; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular pathology; MOLPATH; MPSeq; Myelo; Myeloid neoplasm chrom analy; Next generation sequencing; NGS; Oncology; Point in time; Random; WB; Whole blood; Whole blood or Bone marrow

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Frequently asked questions